{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe urotensin‐II receptor (UTS2R) is a seven‐transmembrane G protein–coupled receptor that mediates the powerful vasoactive effects of its ligand urotensin II. In the cardiovascular system it is expressed by smooth muscle cells, endothelial cells, cardiomyocytes, and even skeletal muscle, and its activation is associated with vascular remodeling in atherosclerosis, arterial hypertension, cardiac hypertrophy, and related disorders. Increased UTS2R expression has been detected in atherosclerotic plaques, aneurysmal tissues, and in conditions such as preeclampsia and liver cirrhosis with portal hypertension, supporting its role in modulating vasoconstrictor/dilator responses and contributing to cardiovascular pathology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nUTS2R activation also plays a key role in inflammatory responses. It acts as a chemoattractant receptor in monocytes and natural killer cells, thereby promoting chemotaxis via pathways involving RhoA and Rho kinase. In models of colonic inflammation, receptor engagement contributes to NF‑κB–mediated cytokine production, underscoring its involvement in immune cell recruitment and local inflammatory cascades."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic and haplotype analyses have linked variants in the urotensin II system to metabolic disturbances. Polymorphisms in the UTS2 gene are associated with increased insulin levels and reduced insulin sensitivity, implicating UTS2R signaling in the pathogenesis of type 2 diabetes mellitus and metabolic syndrome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its cardiovascular and metabolic roles, UTS2R is increasingly recognized as a modulator of tumor growth and progression in various epithelial cancers. Aberrant receptor expression has been reported in adrenal, prostate, colon, bladder, and hepatocellular carcinomas. Activation of UTS2R can promote mitogenic signaling, enhance cell motility and invasion, and is even linked to markers of more aggressive tumor phenotypes. Furthermore, recent studies using receptor antagonists and novel allosteric modulators suggest that targeting UTS2R may provide a therapeutic strategy in cancer management."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural and mechanistic studies have provided important insights into UTS2R activation and ligand binding. Expression studies in cell models such as the human TE‑671 rhabdomyosarcoma line have helped characterize receptor binding properties, including high‐affinity and quasi‑irreversible interactions. High‐resolution NMR and molecular modeling analyses have delineated key receptor domains—especially in extracellular loops and transmembrane segments—that interact with urotensin II and synthetic antagonists such as urantide. Moreover, innovative assays including no‑wash calcium mobilization studies have further refined our understanding of UTS2R pharmacology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, emerging data suggest that UTS2R signaling extends into the central nervous system. In addition to its traditional role in cardiovascular regulation, receptor localization within the nucleus of brain cells and its modulation of GABA(A) receptor function indicate a novel neuromodulatory dimension. Such interactions may affect autophagy, neurotransmission, and ultimately influence processes like astrocyte proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Nicolas Bousette, Lisa Patel, Stephen A Douglas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2004.03.023"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2004.03.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15306183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15306183"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jian-shen Qi, Lisa K Minor, Charles Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2004.11.018"}], "href": "https://doi.org/10.1016/j.peptides.2004.11.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15752584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15752584"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Janet J Maguire, Rhoda E Kuc, Matthias J Kleinz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2007.08.021"}], "href": "https://doi.org/10.1016/j.peptides.2007.08.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17905478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17905478"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Luisa Giuliani, Livia Lenzini, Michele Antonello, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-1131"}], "href": "https://doi.org/10.1210/jc.2008-1131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19001524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19001524"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Panayiota Papadopoulos, Nicolas Bousette, Wisam Al-Ramli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2008.10.044"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2008.10.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19111831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19111831"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Diangang Liu, Jing Chen, Jin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm_00000413"}], "href": "https://doi.org/10.3892/ijmm_00000413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20428787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20428787"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Phillip S Gould, Mei Gu, Jianqin Liao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.110.152074"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.110.152074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20479331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20479331"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shan Gao, Young-Bin Oh, Amin Shah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00438.2010"}], "href": "https://doi.org/10.1152/ajpheart.00438.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20870804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20870804"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "A M D Watson, M Olukman, C Koulis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-013-2837-9"}], "href": "https://doi.org/10.1007/s00125-013-2837-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23344731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23344731"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jean-Pierre Segain, Malvyne Rolli-Derkinderen, Nadine Gervois, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.179.2.901"}], "href": "https://doi.org/10.4049/jimmunol.179.2.901"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17617581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17617581"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yi Yang, Jinpei Zhang, Xi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UII/GPR14 is involved in NF-κB-mediated colonic inflammation in vivo and in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.5069"}], "href": "https://doi.org/10.3892/or.2016.5069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27600191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27600191"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Susumu Suzuki, Zong Wenyi, Masashi Hirai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2004.03.030"}], "href": "https://doi.org/10.1016/j.peptides.2004.03.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15476949"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15476949"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kwok Leung Ong, Louisa Y F Wong, Yu Bun Man, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2006.02.008"}], "href": "https://doi.org/10.1016/j.peptides.2006.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16597476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16597476"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ryo Morimoto, Fumitoshi Satoh, Osamu Murakami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2007.06.025"}], "href": "https://doi.org/10.1016/j.peptides.2007.06.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17686550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17686550"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Paolo Grieco, Renato Franco, Giuseppina Bozzuto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.22933"}], "href": "https://doi.org/10.1002/jcb.22933"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21080343"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21080343"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Diego Brancaccio, Antonio Limatola, Pietro Campiglia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urantide conformation and interaction with the urotensin-II receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Pharm (Weinheim) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ardp.201300269"}], "href": "https://doi.org/10.1002/ardp.201300269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24357333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24357333"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alessandro Federico, Silvia Zappavigna, Marco Romano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Clin Invest (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/eci.12231"}], "href": "https://doi.org/10.1111/eci.12231"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24372535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24372535"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Renato Franco, Silvia Zappavigna, Vincenzo Gigantino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-9966-33-48"}], "href": "https://doi.org/10.1186/1756-9966-33-48"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24893613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24893613"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiao-Tong Yu, Peng-Yan Wang, Zheng-Ming Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of urotensin II and its receptor contributes to human hepatocellular carcinoma growth via activation of the PKC, ERK1/2, and p38 MAPK signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules191220768"}], "href": "https://doi.org/10.3390/molecules191220768"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25514221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25514221"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Ottavio De Cobelli, Carlo Buonerba, Daniela Terracciano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Future Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/fon.15.249"}], "href": "https://doi.org/10.2217/fon.15.249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26381851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26381851"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Alessandro Federico, Silvia Zappavigna, Marcello Dallio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Cancer Drug Targets (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1568009616666160621101248"}], "href": "https://doi.org/10.2174/1568009616666160621101248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27338741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27338741"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Pierre-Michaël Coly, Nicolas Perzo, Vadim Le Joncour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemotactic G protein-coupled receptors control cell migration by repressing autophagosome biogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autophagy (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15548627.2016.1235125"}], "href": "https://doi.org/10.1080/15548627.2016.1235125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27715446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27715446"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Antonietta G Gravina, Marcello Dallio, Concetta Tuccillo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin II receptor expression in patients with ulcerative colitis: a pilot study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Minerva Gastroenterol Dietol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.23736/S1121-421X.19.02602-3"}], "href": "https://doi.org/10.23736/S1121-421X.19.02602-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31293119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31293119"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Hassan Nassour, Tuan Anh Hoang, Ryan D Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.101057"}], "href": "https://doi.org/10.1016/j.jbc.2021.101057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34389356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34389356"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Magdalena Birker-Robaczewska, Céline Boukhadra, Rolf Studer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Recept Signal Transduct Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1081/rrs-120026972"}], "href": "https://doi.org/10.1081/rrs-120026972"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14753294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14753294"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Hong Xin, Yuanping Wang, Matthew J Todd, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of no-wash calcium assay kits: enabling tools for calcium mobilization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomol Screen (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1087057107301522"}], "href": "https://doi.org/10.1177/1087057107301522"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17537987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17537987"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Elodie Lescot, Jana Sopkova-de Oliveira Santos, Nathalie Colloc'h, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proteins (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/prot.22050"}], "href": "https://doi.org/10.1002/prot.22050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18409194"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18409194"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Stéphane Boivin, Isabelle Ségalas-Milazzo, Laure Guilhaudis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2008.02.024"}], "href": "https://doi.org/10.1016/j.peptides.2008.02.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18423797"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18423797"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Radoslaw Debiec, Paraskevi Christofidou, Matthew Denniff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urotensin-II system in genetic control of blood pressure and renal function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0083137"}], "href": "https://doi.org/10.1371/journal.pone.0083137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24391740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24391740"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zhicheng Dai, Yuwen Wang, Zhichong Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel Mutations in UTS2R are Associated with Adolescent Idiopathic Scoliosis in the Chinese Population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Spine (Phila Pa 1976) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/BRS.0000000000003786"}], "href": "https://doi.org/10.1097/BRS.0000000000003786"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33156271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33156271"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Thi-Tuyet Mai Nguyen, Myriam Létourneau, David Chatenet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2011.12.022"}], "href": "https://doi.org/10.1016/j.biocel.2011.12.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22245063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22245063"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Laurence Desrues, Thomas Lefebvre, Céline Lecointre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0036319"}], "href": "https://doi.org/10.1371/journal.pone.0036319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22563490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22563490"}]}]}]}